Cagrilintide, CagriSema, Tirzepatide & Retatrutide: My Experience With Weight-Loss Combinations.
Disclaimer: This article is for informational and educational purposes only. Products sold as research peptides are intended for laboratory research and are not for human consumption. Nothing in this article is intended to diagnose, treat, cure, or prevent any medical condition.
If you've been following GLP-1s, peptides, or weight-loss medications for a while, you already know how quickly things are changing.
For a long time, semaglutide was the medication everyone was talking about. Then tirzepatide came along and added GIP into the mix. Now retatrutide has been getting a ton of attention because it works on three different pathways.
But lately, cagrilintide is the one I keep seeing more and more people talk about.
What caught my attention about cagrilintide is that it isn't just another GLP-1. It works differently, which is also why people are becoming interested in combining it with medications like semaglutide, tirzepatide, and retatrutide.
I've personally tried a few different combinations during my own weight-loss journey, including tirzepatide by itself, tirzepatide with a small amount of retatrutide, retatrutide with cagrilintide, and now tirzepatide with cagrilintide.
And one thing I've learned is that what sounds the strongest on paper isn't always what feels the best in real life.
For me, weight loss isn't only about watching the number on the scale go down. One of the biggest things I pay attention to is food noise, how often I'm thinking about food, cravings, snacking, and whether I actually feel satisfied after eating.
That's a big reason I wanted to write this article.
I'm going to explain cagrilintide in a way that's hopefully easy to understand, talk about CagriSema and the clinical trial results, and then share my own experience with cagrilintide combined with tirzepatide and retatrutide.
Just keep in mind that some of these combinations are still experimental and don't have the same research behind them as medications that have gone through large clinical trials. I'm sharing my personal experience, not giving medical advice.
What Is an Amylin Analog, How Is It Different From a GLP-1?
Before getting into cagrilintide, it helps to know a little about amylin.
Amylin is a hormone our bodies naturally release after we eat. It works alongside insulin and helps tell the brain that we've eaten and are getting full.
Basically, it's part of the body's natural system for saying, "Okay, we've had enough food."
Cagrilintide is designed to act somewhat like this natural hormone, but it lasts much longer in the body.
That's what makes it different from medications like semaglutide.
Semaglutide works on GLP-1 receptors. Tirzepatide works on GLP-1 and GIP. Retatrutide works on GLP-1, GIP, and glucagon.
Cagrilintide works through the amylin pathway instead.
GLP-1 vs. Amylin.
GLP-1 medications can help with things like:
• Reducing appetite.
• Helping you feel full sooner.
• Slowing digestion.
• Helping control blood sugar.
• Reducing how much food you want to eat.
Amylin can also help with appetite and fullness, but it gets there in a different way.
That's why I don't really think of cagrilintide as something that's supposed to replace GLP-1s.
What I find more interesting is the idea of using the two pathways together.
That's basically what researchers are doing with CagriSema.
What Is Cagrilintide?
Cagrilintide is a long-acting amylin analog being studied for weight loss and obesity.
The easiest way I can describe it is that it's being studied for its ability to help people feel fuller, eat less, and have better control over hunger.
And for me, one of the most interesting parts is its possible effect on food noise.
If you've dealt with food noise, you probably know exactly what I mean.
It's not always actual hunger.
Sometimes it's thinking about what you're going to eat next even though you just ate. Walking through the kitchen and wanting to grab something. Craving something sweet after dinner. Thinking about snacks all afternoon.
It's basically food taking up way more space in your brain than you want it to.
Weight loss requires eating less than your body is using, but actually sticking to that is a lot harder when you're hungry or thinking about food all day.
That's one reason compounds that affect appetite and fullness have gotten so much attention.
What Is Cagrilintide Being Studied For?
Researchers are looking at cagrilintide for things like:
• Feeling fuller: It may help you feel satisfied with less food.
• Lower appetite: Some people may naturally eat less because they aren't as hungry.
• Smaller portions: Feeling full faster can make it easier to stop eating.
• Longer-lasting fullness: It may slow digestion and help meals feel more satisfying.
• Better appetite control: This is one of the biggest reasons people are interested in it.
• Combining it with GLP-1s: Since it works differently, it may add something that GLP-1 medications don't do on their own.
What Do the Cagrilintide Clinical Trials Show?
This is where cagrilintide gets really interesting.
Cagrilintide has been studied on its own, but it has also been studied together with semaglutide as CagriSema.
One of the biggest studies was the REDEFINE 1 trial, which lasted 68 weeks.
Researchers compared cagrilintide, semaglutide, CagriSema, and placebo.
Average weight loss was around:
• Cagrilintide: 11.5%
• Semaglutide: 14.9%
• CagriSema: 20.4%
• Placebo: 3%
Researchers also looked at what the results could look like if people stayed on treatment as planned.
Those numbers were:
• Cagrilintide: 11.8%
• Semaglutide: 16.1%
• CagriSema: 22.7%
• Placebo: 2.3%
I think those numbers are pretty interesting because cagrilintide clearly did something on its own.
But when they combined it with semaglutide, the average weight loss was even higher.
And that's really where the idea behind these combinations starts to make sense.
What Is CagriSema?
CagriSema is a combination of cagrilintide and semaglutide.
This is probably the cagrilintide combination with the most real research behind it right now.
Semaglutide works through GLP-1.
Cagrilintide works through amylin.
So instead of trying to get everything from one appetite pathway, the combination goes after hunger and fullness in two different ways.
And based on the studies so far, that seems to make a difference.
CagriSema Weight-Loss Results.
In the 68-week REDEFINE 1 trial, CagriSema produced around 20.4% average weight loss using one of the main ways the researchers analyzed the results.
When they looked at people as if they stayed on treatment as planned, the average was about 22.7%.
Around 40% of people reached at least 25% weight loss in that analysis.
For comparison, semaglutide was around 16.1%, while cagrilintide was around 11.8%.
That's a pretty noticeable difference.
To me, this is one of the best examples we have right now showing that GLP-1 and amylin may work really well together.
Possible Benefits of CagriSema.
Based on the research so far, CagriSema may offer:
• Better appetite control.
• More fullness after eating.
• Greater average weight loss than either medication alone.
• Less overall food intake.
• Improvements in metabolic health along with weight loss.
• Once-weekly dosing in the clinical trials.
CagriSema has also been studied in people with type 2 diabetes, where researchers saw improvements in both weight and blood sugar.
Is CagriSema FDA Approved?
Not yet.
This is something I think is important to clear up because I've seen people online talk about it like it's already available as an approved medication.
Novo Nordisk submitted CagriSema to the FDA for weight management in December 2025.
As of August 2026, it is still considered investigational and hasn't received FDA approval yet.
So it's definitely getting closer, but submitted for approval does not mean approved.
Why Are People Talking About Cagrilintide With Tirzepatide or Retatrutide?
This is where things move away from established clinical research and more into what people are discussing and experimenting with in the peptide community.
Cagrilintide and semaglutide have been studied together in large clinical trials as CagriSema.
The same thing hasn't happened yet with cagrilintide + tirzepatide or cagrilintide + retatrutide.
People are interested in the combinations because each compound works a little differently.
Tirzepatide works on:
GLP-1 + GIP
Cagrilintide adds:
Amylin
Retatrutide works on:
GLP-1 + GIP + glucagon
And adding cagrilintide would also bring in:
Amylin
When you look at it that way, you can understand why people are curious.
But something sounding good in theory isn't the same thing as knowing that it's safe or better.
We don't have the same large studies showing what happens when cagrilintide is combined with tirzepatide or retatrutide.
That's why anything I say about those combinations comes from my own experience, not clinical proof.
Tirzepatide for Weight Loss.
Tirzepatide has honestly been a huge part of my own weight-loss journey.
It works on both GIP and GLP-1, which is why it's often described as a dual agonist.
It's FDA approved for chronic weight management under the name Zepbound for people who meet the requirements.
The SURMOUNT-1 trial included more than 2,500 adults and lasted 72 weeks.
Average weight loss was around:
• 5 mg: 15%
• 10 mg: 19.5%
• 15 mg: 20.9%
Those are impressive numbers.
But when you're actually the person taking something, I don't think the percentage tells the whole story.
For me, the biggest benefit from tirzepatide has been appetite control.
It helped me feel satisfied with less food and made it much easier to stick to what I was trying to do.
Why Would Someone Add Cagrilintide to Tirzepatide?
The main reason people talk about this combination is because the two work differently.
Tirzepatide already works through GLP-1 and GIP.
Cagrilintide adds the amylin pathway.
The idea is that instead of simply increasing tirzepatide, adding another type of appetite signal might help with things like:
• Feeling fuller.
• Reducing food noise.
• Staying satisfied between meals.
• Getting through a plateau.
• Improving appetite control.
Again, these are reasons people are interested in the combination. They aren't proven benefits of this exact combination.
And I also think it's important to say that more appetite suppression isn't always better.
You still need to eat.
You still need protein, fluids, vitamins, and enough nutrition to actually take care of your body.
My goal has never been to completely lose the ability to eat.
For me, the goal is to make eating feel easier to control.
And personally, tirzepatide with a small amount of cagrilintide has been my favorite combination I've tried so far.
Retatrutide for Weight Loss.
Retatrutide is probably one of the most hyped weight-loss compounds right now.
And I understand why.
Semaglutide works on one main receptor.
Tirzepatide works on two.
Retatrutide works on three:
• GLP-1.
• GIP.
• Glucagon.
That's why you'll sometimes hear people call it a triple agonist.
Retatrutide's early trial results got a lot of attention because people lost a large amount of weight.
In a phase 2 study, people taking the highest dose lost an average of around 24.2% of their body weight at 48 weeks.
And newer phase 3 results have been even more impressive.
Retatrutide Phase 3 Results.
In the TRIUMPH-1 trial, average weight loss at 80 weeks was around:
• 4 mg: 19%
• 9 mg: 25.9%
• 12 mg: 28.3%
In one group of participants who continued longer, average weight loss reached around 30.3% at 104 weeks with the 12 mg dose.
Those numbers are huge.
But retatrutide is still investigational.
And those results don't automatically mean combining it with something else will make it even better.
Why Are People Combining Retatrutide With Cagrilintide?
Again, it comes down to the different pathways.
Retatrutide already works on GLP-1, GIP, and glucagon.
Cagrilintide adds amylin.
So on paper you're looking at:
GLP-1 + GIP + glucagon + amylin.
You can see why people look at that and think, Wow, that sounds powerful.
People are interested in the combination for things like:
• More appetite suppression.
• Better fullness.
• Less food noise.
• More control over eating.
• Getting multiple pathways working at once.
But we don't have large human trials proving that adding cagrilintide to retatrutide works better than retatrutide alone.
And my own experience was actually a perfect example of why I don't think more automatically means better.
On paper, retatrutide plus cagrilintide sounded amazing to me.
In real life, it wasn't my favorite.
My Experience With Tirzepatide, Retatrutide and Cagrilintide.
This is probably the part of the article I care about the most because I can only read so many studies before I want to know what something actually feels like.
I started this part of my weight-loss journey using tirzepatide by itself.
And honestly, tirzepatide worked really well for me.
It helped with my appetite, I was getting full faster, and I wasn't constantly wanting to eat.
Eventually, though, I started wondering what else I could do instead of simply continuing to increase my tirzepatide dose.
That's when I started experimenting with different combinations.
Adding Retatrutide to Tirzepatide.
The first thing I tried was adding a small amount of retatrutide to tirzepatide.
At the time, the idea made sense to me.
Tirzepatide already works on GLP-1 and GIP, and retatrutide also brings glucagon into the picture.
I thought I might notice a huge difference.
But I really didn't.
It wasn't bad, but I didn't feel like I was getting enough extra benefit from it to make it worth continuing.
That was one of my first big lessons:
More doesn't automatically mean better.
You can look at all these different pathways and think a combination should be incredible, and then your body might just respond with, Eh.
The biggest thing I still wanted more control over was food noise.
Trying Retatrutide With Cagrilintide.
After that, I decided to try retatrutide with a small amount of cagrilintide.
This one sounded even more interesting to me.
Retatrutide was covering GLP-1, GIP, and glucagon, while cagrilintide was bringing in amylin.
On paper, it sounded like it should be almost perfect.
And I did get results from it.
I don't want to make it sound like it did nothing because it definitely wasn't a complete failure.
It just didn't give me the exact type of appetite control I was looking for.
The biggest thing I felt was still missing was that really noticeable drop in food noise.
I wasn't looking to never feel hungry.
I wasn't trying to get to the point where food made me sick or I couldn't eat.
I wanted to be able to think, I'm hungry, eat a reasonable meal, feel satisfied, and then go on with my day without thinking about food again 30 minutes later.
That's the sweet spot I was looking for.
Retatrutide and cagrilintide just didn't quite get me there.
Going Back to Tirzepatide With Cagrilintide.
Eventually, I went back to the compound that had worked best for me from the beginning, tirzepatide.
But this time, I paired it with a small amount of cagrilintide.
And for me, that's when everything really clicked.
The biggest difference has been my food noise.
It gets incredibly quiet.
I'm not constantly thinking about what I can snack on.
I'm not walking into the kitchen out of habit.
I'm not spending half the day trying to figure out whether I'm hungry or just craving something.
Food isn't taking up nearly as much space in my brain.
But the part I really like is that I can still eat.
I don't want appetite suppression that's so strong I can't get enough food down.
I still want to be able to eat protein, enjoy my meals, and actually nourish my body.
With this combination, I feel like I can do that.
I just get satisfied much faster, and once I'm done eating, I'm done.
For me, it feels much more balanced.
What Tirzepatide + Cagrilintide Feels Like for Me.
The easiest way I can describe it is:
Someone turned the volume down.
The food thoughts are still technically there, but they're way quieter.
I'm not relying on willpower all day long.
I'm not starving.
But I'm also not so uninterested in food that eating becomes a chore.
I can recognize hunger, eat, feel full, and move on.
That's exactly what I was hoping for.
I've also personally done well with the combination without experiencing major negative side effects.
But that's my experience.
Someone else could react completely differently.
And because tirzepatide and cagrilintide haven't been studied together in the same way CagriSema has, we don't have enough information to say what the ideal combination would be or how it compares long term.
What Trying These Different Combinations Has Taught Me.
One of the biggest things I've learned is that the compound with the craziest clinical trial numbers isn't automatically going to be the one I like the most.
Retatrutide is a perfect example.
Its weight-loss numbers are incredible.
But a study telling me that people lost an average of 28% of their body weight doesn't tell me whether my food noise is going to disappear.
It doesn't tell me whether I'm going to feel satisfied after lunch.
It doesn't tell me whether I'm going to spend all afternoon thinking about dinner.
And it definitely doesn't tell me how I'm going to feel mentally while using it.
There's so much more to weight loss than the scale.
For me:
Tirzepatide alone: Worked really well.
Tirzepatide + a small amount of retatrutide: Didn't impress me enough to continue.
Retatrutide + cagrilintide: Worked okay, but wasn't my favorite for food noise.
Tirzepatide + cagrilintide: Has been my favorite combination for appetite control and quieting food noise.
That doesn't mean it's going to be someone else's favorite.
It just means that's what my body responded to best.
I think we spend so much time asking:
"Which one causes the most weight loss?"
But I think another really important question is:
"Which one actually makes losing weight easier for me to stick with?"
Those can be two completely different answers.
Cagrilintide vs. CagriSema vs. Tirzepatide + Cagrilintide vs. Retatrutide + Cagrilintide.
One thing I really want to make clear is that these don't all have the same amount of research behind them.
Cagrilintide Alone.
Cagrilintide has been studied in human clinical trials.
In REDEFINE 1, people taking cagrilintide alone lost around 11.5% to 11.8% of their body weight on average at 68 weeks, depending on how the researchers looked at the results.
CagriSema is cagrilintide plus semaglutide.
This combination has gone through large phase 3 clinical trials.
In REDEFINE 1, average weight loss was around 20.4% to 22.7%.
It has been submitted to the FDA for weight management, but as of August 2026 it is not FDA approved yet.
This is something people are talking about and experimenting with in peptide and biohacking communities.
The idea makes sense because tirzepatide works on GLP-1 and GIP while cagrilintide works through amylin.
But we don't have the same large clinical trials for this combination.
I've personally had a very positive experience with it, especially when it comes to appetite and food noise, but that's still just my personal experience.
Retatrutide already works on GLP-1, GIP, and glucagon, so adding cagrilintide adds yet another pathway.
It's an interesting idea, but again, there isn't enough research yet to say that it's better than retatrutide alone.
For me, it worked okay.
But I personally preferred tirzepatide with cagrilintide.
Are Amylin + GLP-1 Combinations the Next Big Thing in Weight Loss?
This is really what I find most interesting about cagrilintide.
For a while, it seemed like everything in weight loss was about GLP-1.
Then tirzepatide came along and added GIP.
Then retatrutide added glucagon.
Now CagriSema is showing us that maybe the next step isn't always adding another GLP-1-related pathway.
Maybe amylin is going to become a much bigger part of the conversation.
Cagrilintide works differently, and the CagriSema trials showed that putting cagrilintide and semaglutide together led to more average weight loss than either one alone.
That doesn't mean every cagrilintide combination is automatically going to work better.
And it definitely doesn't mean throwing more compounds together is always a good idea.
But it does show something I've started to think about a lot:
Weight and appetite are controlled by a lot of different systems in the body.
So it makes sense that future weight-loss medications may use more than one pathway at a time.
And that's a big reason I think cagrilintide is worth paying attention to.
Final Thoughts on Cagrilintide and GLP-1 Combinations.
When I first started learning about GLP-1s and peptides, I looked at everything separately.
What does semaglutide do?
What does tirzepatide do?
How much weight are people losing on retatrutide?
What does cagrilintide do?
Now I look at it a little differently.
I think a lot of the future of weight-loss research may be about figuring out which pathways work well together.
Cagrilintide is a really good example because it isn't just another GLP-1.
It works through amylin, which gives researchers another way to target appetite and fullness.
Cagrilintide has shown that it can help with weight loss by itself.
But when it was combined with semaglutide in CagriSema, the results were even better.
In REDEFINE 1, average weight loss with CagriSema reached around 20.4% to 22.7%, compared with around 14.9% to 16.1% for semaglutide and around 11.5% to 11.8% for cagrilintide.
Tirzepatide and retatrutide also have very impressive numbers behind them.
But if there's one thing my own experience has taught me, it's that the medication with the biggest percentage in a study isn't automatically the one I'm going to like best.
I've tried tirzepatide alone.
I've tried adding a small amount of retatrutide.
I've tried retatrutide with cagrilintide.
And I eventually came back to tirzepatide, this time with cagrilintide.
For me, that has been my sweet spot so far.
My food noise is quiet.
My appetite feels controlled without feeling completely gone.
I can still eat when I need to.
I'm not constantly thinking about food.
And I don't feel like I'm fighting cravings all day.
That balance has made a huge difference for me.
But I also want to be really clear that my personal experience isn't the same thing as clinical research.
Cagrilintide with tirzepatide and cagrilintide with retatrutide haven't been studied the same way CagriSema has.
Just because people are talking about these combinations in peptide groups doesn't mean they're established or FDA-approved treatments.
CagriSema is different because researchers have actually studied the combination in thousands of people, and Novo Nordisk has submitted it to the FDA.
Research suppliers have also started offering more cagrilintide products and combination research formulations. I understand why people find those interesting, especially when having two compounds together sounds easier than dealing with them separately.
Pay attention to the research, know when something is backed by studies versus personal stories, and remember that stronger doesn't always mean better.
For me, sustainable weight loss isn't about never wanting food again.
It's about finally getting to a place where I'm controlling the food instead of feeling like the food is controlling me.
And after everything I've tried and learned during this journey, that's the part that matters most to me.
Frequently Asked Questions.
1. What is Cagrilintide?
Cagrilintide is a long-acting synthetic amylin analog being studied for obesity and weight management. It is designed to mimic the effects of amylin, a natural hormone involved in fullness, appetite control, gastric emptying, and post-meal glucagon regulation.
2. Is Cagrilintide a GLP-1?
No. Cagrilintide is not a GLP-1 receptor agonist. It works through amylin-related pathways, which is one reason researchers are interested in combining it with GLP-1 medications that work through different mechanisms.
3. How much weight loss has Cagrilintide produced in clinical trials?
In the REDEFINE 1 trial, cagrilintide alone produced approximately 11.5% to 11.8% average body-weight reduction over 68 weeks, depending on the analysis used.
4. What is CagriSema?
CagriSema is an investigational combination of cagrilintide and semaglutide. It combines amylin-receptor activity with GLP-1 receptor activity to target appetite, satiety, and metabolic regulation through complementary pathways.
5. How much weight loss has CagriSema produced?
In REDEFINE 1, CagriSema produced approximately 20.4% average weight loss in the treatment-policy analysis and 22.7% in the adherence-focused analysis after 68 weeks.
6. Is CagriSema FDA approved?
Not yet. CagriSema has been submitted to the FDA for chronic weight management, but it remains investigational as of August 2026.
7. Can Cagrilintide be combined with Tirzepatide?
People in peptide and biohacking communities have experimented with combining cagrilintide and tirzepatide because the two compounds work through different pathways. However, this specific combination does not currently have the same large-scale human clinical trial evidence as CagriSema.
8. Can Cagrilintide be combined with Retatrutide?
Cagrilintide and retatrutide are also discussed as a potential combination because retatrutide targets GLP-1, GIP, and glucagon receptors while cagrilintide works through amylin-related pathways. Research on this exact combination in humans is still very limited.
9. Which combination worked best for me?
In my personal experience, tirzepatide combined with a small amount of cagrilintide has worked best for controlling my hunger and food noise. Retatrutide with cagrilintide worked okay for me, but it did not provide the same level of food-noise suppression.
10. Are Cagrilintide, CagriSema, Tirzepatide, and Retatrutide the same thing?
No. They all work differently. Cagrilintide is an amylin analog, semaglutide is a GLP-1 receptor agonist, tirzepatide targets GLP-1 and GIP receptors, and retatrutide targets GLP-1, GIP, and glucagon receptors. CagriSema combines cagrilintide with semaglutide.
~ Written by Rachael Tam.
~ Photos by Rachael Tam.
~ Topic - Glps and Weight-Loss.
~ For PR Offers, email me at - bfh.artistry@gmail.com.
~ My Linktree link - https://linktr.ee/rachaeltam.
~ Check out my ShopMy Store.
~ Shop my Amazon Storefront.
~ Check out my Walmart Storefront.
~ Shop my Ulta Beauty Storefront.
~ Check out my Target Storefront.
~ Shop my Kitsch Store.
~ Check out my Sephora Storefront.
~ Join my Peptide & Biohacking discord group.
Comments
Post a Comment